Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1053 (LINC01053) is a non-protein coding gene transcribing a lincRNA, a subclass of long non-coding RNAs (lncRNAs) that do not overlap protein-coding genes. LincRNAs serve regulatory functions in the genome including fine-tuning gene expression, altering chromatin architecture, stabilizing RNA molecules, and modulating transcriptional processes, often with marked tissue specificity. While some lincRNAs are implicated in human diseases such as cancer, few individual members (including LINC01053) have been thoroughly characterized with respect to clinical roles or direct molecular interactions. LINC01053 is cataloged in human genomic databases (NCBI, Ensembl), but as a non-coding RNA, it is not considered a traditional therapeutic drug target. LINC01053 is neither a receptor, enzyme, nor conventional drug target; it is a lincRNA gene, classified within the long non-coding RNA family, and functions mainly in epigenetic/transcriptional regulation. LincRNAs contribute to gene expression regulation, chromatin dynamics, and may act as enhancers or scaffolds for protein complexes. While some lincRNAs have emerging roles in cancer or other diseases, specific roles for LINC01053 remain uncharacterized. No therapeutic drugs, mechanisms of action, or safety concerns are specifically linked to LINC01053. If details on lincRNAs as a class are required, there is abundant literature on their role in gene regulation and human disease, but for LINC01053 specifically, available information remains basic and descriptive.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1053 (LINC01053).